BCR-ABL-IN-9
BCR-ABL-IN-9 (Compound B1) is a BCR-ABL inhibitor that achieves sustained BCR-ABL suppression by forming stable covalent bonds with the ABL kinase. BCR-ABL-IN-9 is also effective in inhibiting the activity of the ABL kinase (IC50 = 1.2 nM). BCR-ABL-IN-9 possesses anticancer activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Formel: C22H20N4O3
- Molecular Weight:388.42
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
IC50: 1.2 nM (ABL)[1]
Chemical Information
-
Molecular Weight 388.42
-
Formel C22H20N4O3
-
SMILES
OC1=CC=C(OC)C(C2=CNC3=NC=C(C4=CC(C(N(C)C)=O)=CN=C4)C=C23)=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
BCR-ABL-IN-9 Related Classifications
HY-169230 Related Classifications
Powered by Bioz